Korean J Gastroenterol.  2012 Aug;60(2):79-85. 10.4166/kjg.2012.60.2.79.

DNA Double Strand Breaks in Gastric Epithelium with Helicobacter pylori Infection

Affiliations
  • 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. kimss@catholic.ac.kr
  • 2Department of Pathology, The Catholic University of Korea College of Medicine, Seoul, Korea.

Abstract

BACKGROUND/AIMS
DNA double strand breaks (DSB) is one of the critical types of DNA damage. If unrepaired, DSB is accumulated in the nucleus of cells, the cells become apoptotic or transform to tumor by way of genomic instability. Some of malignant cancers and its premalignant lesions were proven to have DSB in their nuclei. There was no report that Helicobacter pylori (H. pylori), the gastric carcinogen, induce DNA DSB in gastric epithelium in vivo. The aim of this study was to investigate whether H. pylori induce DSB in the gastric epithelial cells of chronic gastritis.
METHODS
Immunohistochemical stains were performed for the DSB markers, phospho-53BP1 and gammaH2AX, in the gastric epithelium derived from 44 peptic ulcer disease patients before and after H. pylori eradication. DNA fragmentation assay was performed in the cell line to investigate the DNA damage by H. pylori infection.
RESULTS
The mean expression score of gammaH2AX was significantly higher in the H. pylori infected gastric epithelium as compared to the H. pylori eradicated gastric epithelium (8.8+/-5.5 vs. 6.2+/-5.3 respectively; p=0.008). The expression score of phospho-53BP1 between before and after eradication of H. pylori was not statistically different, but tended to be higher in H. pylori infection. DNA fragmentation was developed significantly more in the cell lines after infection with H. pylori.
CONCLUSIONS
DSB of DNA damage was typical feature of H. pylori infection in the gastric epithelium.

Keyword

Gastric mucosa; Helicobacter pylori; DNA breaks, double stranded; Gamma-H2AX protein, human; 53BP1 protein, human

MeSH Terms

Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents/therapeutic use
Cell Line, Tumor
DNA/metabolism
*DNA Breaks, Double-Stranded
Female
Gastric Mucosa/*metabolism
Helicobacter Infections/drug therapy/*metabolism
Helicobacter pylori/*drug effects/pathogenicity
Histones/genetics/metabolism
Humans
Immunohistochemistry
Intracellular Signaling Peptides and Proteins/genetics/metabolism
Male
Middle Aged
Peptic Ulcer/genetics/pathology

Figure

  • Fig. 1 Immunohistochemistry for γH2AX and phospho-53BP1 proteins were detected in the nuclei of epithelial and interstitial inflammatory cells of the gastric mucosa (×200). (A) γH2AX before Helicobacter pylori (H. pylori) eradication. (B) γH2AX after eradication. (C) Phospho-53BP1 before eradication. (D) Phospho-53BP1 after eradication. Expression of γH2AX reduced in gastric epithelial cells after the eradication of H. pylori and phospho-53BP1 tended to be decreased after H. pylori eradication.

  • Fig. 2 Change of γH2AX and phospho-53BP1 expressions in the gastric epithelial cells of 44 patients following eradication of Helicobacter pylori (H. pylori). (A) The percentage of epithelial cells expressing γH2AX reduced significantly after eradication of H. pylori. (B) Gastric epithelial cells expressing phospho-53BP1 tended to be decreased after H. pylori eradication. The thick black bars indicate the mean values (**p<0.01). Hp, H. pylori.

  • Fig. 3 The induction of DNA fragmentation in Helicobacter pylori (H. pylori) infected AGS cells. Lane 2 and lane 3 in which H. pylori were infected induced DNA fragmentation in cells. Lane 1 indicated AGS, lane 2 was HS3C, lane 3 was AGS infected by H. pylori, and lane 4 was H. pylori only. M indicates molecular marker.


Reference

1. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001. 345:784–789.
2. Moss SF, Blaser MJ. Mechanisms of disease: Inflammation and the origins of cancer. Nat Clin Pract Oncol. 2005. 2:90–97.
3. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001. 121:823–829.
4. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002. 2:28–37.
5. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004. 4:688–694.
6. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008. 319:1352–1355.
7. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007. 73:1697–1702.
8. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut. 1996. 38:498–501.
9. Peek RM Jr, Wirth HP, Moss SF, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology. 2000. 118:48–59.
10. Machado AM, Figueiredo C, Seruca R, Rasmussen LJ. Helicobacter pylori infection generates genetic instability in gastric cells. Biochim Biophys Acta. 2010. 1806:58–65.
11. Machado AM, Figueiredo C, Touati E, et al. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res. 2009. 15:2995–3002.
12. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology. 2002. 123:542–553.
13. Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003. 124:1408–1419.
14. Meira LB, Bugni JM, Green SL, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008. 118:2516–2525.
15. Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer. Gut. 2005. 54:1321–1331.
16. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005. 434:907–913.
17. Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008. 36:5678–5694.
18. Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008. 8:957–967.
19. Schultz LB, Chehab NH, Malikzay A, DiTullio RA Jr, Stavridi ES, Halazonetis TD. The DNA damage checkpoint and human cancer. Cold Spring Harb Symp Quant Biol. 2000. 65:489–498.
20. Kim JH, Kim SS, Byun SW, et al. Double strand break of DNA in gastric adenoma and adenocarcinoma. Korean J Gastroenterol. 2010. 55:19–25.
21. Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol. 2007. 13:3726–3729.
22. Eguchi H, Herschenhous N, Kuzushita N, Moss SF. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. Cancer Res. 2003. 63:4739–4746.
23. Toller IM, Neelsen KJ, Steger M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A. 2011. 108:14944–14949.
24. Jang SH, Lim JW, Morio T, Kim H. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radic Biol Med. 2012. 52:607–615.
25. Luger K. Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev. 2003. 13:127–135.
26. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev. 2002. 12:162–169.
27. Takahashi A, Ohnishi T. Does gammaH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett. 2005. 229:171–179.
28. FitzGerald JE, Grenon M, Lowndes NF. 53BP1: function and mechanisms of focal recruitment. Biochem Soc Trans. 2009. 37:897–904.
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr